Role of homoeopathy in leukemia: an updated holistic review
Abstract
Leukemia is a common malignancy in children and adults that occurs when alterations in normal cell regulatory processes cause uncontrolled proliferation of hematopoietic stem cells in the bone marrow. It is a clonal proliferation of hematopoietic stem cells in the bone marrow. The four broad subtypes most likely to be encountered by primary care physicians are acute lymphoblastic, acute myelogenous, chronic lymphocytic, and chronic myelogenous. Acute lymphoblastic leukemia occurs more often in children, whereas the other subtypes are more common in adults. This review summarizes the epidemiology, pathophysiology, clinical presentation, diagnosis, and conventional management of leukemia, and provides an updated overview of homoeopathic philosophy, miasmatic understanding, reportorial guidance, therapeutic indications, and available research related to leukemia. When it comes to providing a secure and efficient method of treating leukemia, homoeopathy can be a crucial component of integrative medicine.
Keywords:
Leukemia, Blood cancer, Homoeopathy
Downloads
Download data is not yet available.
References
1. Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harb Perspect Med. 2020;10(6):034819.
2. Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):14-24.
3. Snyder R. Leukemia and benzene. Int J Environ Res Public Health. 2012;9(8):2875-93.
4. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083-95.
5. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89(9):731-8.
6. Stieglitz E, Loh ML. Genetic predispositions to childhood leukemia. Ther Adv Hematol. 2013;4(4):270-90.
7. Harrison's Principles of Internal Medicine, 16th Edition, Chapter 97. Malignancies of Lymphoid Cells. Clinical Features, Treatment, and Prognosis of Specific Lymphoid Malignancies.
8. Finding Cancer Statistics » Cancer Stat Fact Sheets »Chronic Lymphocytic Leukemia. National Cancer Institute. 2015.
9. Colvin GA, Elfenbein GJ. The latest treatment advances for acute myelogenous leukemia. Med Health R I. 2003;86(8):243–6.
10. Patients with Chronic Myelogenous Leukemia Continue to Do Well on Imatinib at 5-Year Follow-Up. Medscape Medical News. 2006.
11. Updated Results of Tyrosine Kinase Inhibitors in CML. ASCO 2006 Conference Summaries
12. Else M, Ruchlemer R, Osuji N; et al.Long remissions in hairy cell leukemia with purineanalogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer. 2005;104(11):2442–8.
13. Chennamadhavuni A, Iyengar V, Mukkamalla SKR, Shimanovsky A. Leukemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
14. Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harb Perspect Med. 2020;10(6):034819.
15. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875-91.
16. Rabizadeh E, Pickholtz I, Barak M, Isakov E, Zimra Y, Froom P. Acute leukemia detection rate by automated blood count parameters and peripheral smear review. Int J Lab Hematol. 2015;37(1):44-9.
17. Widick P, Winer ES. Leukocytosis and Leukemia. Prim Care. 2016;43(4):575-87
18. Sabath DE. Leukemia. In: Maloy S, Hughes K, editors. Brenner’s Encyclopedia of Genetics (Second Edition). San Diego: Academic Press; 2013. p. 226-7.
19. Devine SM, Larson RA. Acute leukemia in adults: recent developments in diagnosis and treatment. CA Cancer J Clin. 1994;44(6):326-52.
20. Ebb DH, Weinstein HJ. Diagnosis and treatment of childhood acute myelogenous leukemia. Pediatr Clin North Am. 1997;44(4):847-62.
21. SEER Stat Fact Sheets: Leukemia. National Cancer Institute. 2024.
22. American Cancer Society. Survival rates for childhood leukemia. Archived. 2014.
23. Stock W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc HematolEduc Program. 2010;2010:21-29.
24. Howard SC, Trifilio S, Gregory TK, Baxter N, McBride A. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Ann Hematol. 2016;95(4):563-73.
25. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875-91.
26. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083-95.
27. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427-31
28. Hahnemann S. Organon of Medicine: Fifth and Sixth Edition Combined. Boericke W, translator. New Delhi: B. Jain Publishers; 2002.
29. Kent JT. Repertory of the Homeopathic Materia Medica. 6th ed. New Delhi: B. Jain Publishers; 1998.
30. Phatak SR. A Concise Repertory of Homoeopathic Medicines. 2nd ed. New Delhi: B. Jain Publishers; 1996.
31. Murphy R. Homoeopathic Medical Repertory. 3rd ed. Virginia: Lotus Health Institute; 2010.
32. Roberts HA. The Principles and Art of Cure by Homoeopathy. New Delhi: B. Jain Publishers; 2002.
33. Anshutz EP. A Guide to the Twelve Tissue Remedies. New Delhi: B. Jain Publishers; 2002.
34. Boericke W. Pocket Manual of Homoeopathic Materia Medica & Repertory. New Delhi: B. Jain Publishers; 2002.
35. Dewey WA. Practical Homoeopathic Therapeutics. New Delhi: B. Jain Publishers; 2002.
36. Shaji Kumar RT. Holistic treatment of chronic myeloid leukaemia with adjuvant homoeopathic therapy: A case report. Ind J Res Homeopat. 2020;14(1):50.
2. Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):14-24.
3. Snyder R. Leukemia and benzene. Int J Environ Res Public Health. 2012;9(8):2875-93.
4. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083-95.
5. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89(9):731-8.
6. Stieglitz E, Loh ML. Genetic predispositions to childhood leukemia. Ther Adv Hematol. 2013;4(4):270-90.
7. Harrison's Principles of Internal Medicine, 16th Edition, Chapter 97. Malignancies of Lymphoid Cells. Clinical Features, Treatment, and Prognosis of Specific Lymphoid Malignancies.
8. Finding Cancer Statistics » Cancer Stat Fact Sheets »Chronic Lymphocytic Leukemia. National Cancer Institute. 2015.
9. Colvin GA, Elfenbein GJ. The latest treatment advances for acute myelogenous leukemia. Med Health R I. 2003;86(8):243–6.
10. Patients with Chronic Myelogenous Leukemia Continue to Do Well on Imatinib at 5-Year Follow-Up. Medscape Medical News. 2006.
11. Updated Results of Tyrosine Kinase Inhibitors in CML. ASCO 2006 Conference Summaries
12. Else M, Ruchlemer R, Osuji N; et al.Long remissions in hairy cell leukemia with purineanalogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer. 2005;104(11):2442–8.
13. Chennamadhavuni A, Iyengar V, Mukkamalla SKR, Shimanovsky A. Leukemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
14. Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harb Perspect Med. 2020;10(6):034819.
15. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875-91.
16. Rabizadeh E, Pickholtz I, Barak M, Isakov E, Zimra Y, Froom P. Acute leukemia detection rate by automated blood count parameters and peripheral smear review. Int J Lab Hematol. 2015;37(1):44-9.
17. Widick P, Winer ES. Leukocytosis and Leukemia. Prim Care. 2016;43(4):575-87
18. Sabath DE. Leukemia. In: Maloy S, Hughes K, editors. Brenner’s Encyclopedia of Genetics (Second Edition). San Diego: Academic Press; 2013. p. 226-7.
19. Devine SM, Larson RA. Acute leukemia in adults: recent developments in diagnosis and treatment. CA Cancer J Clin. 1994;44(6):326-52.
20. Ebb DH, Weinstein HJ. Diagnosis and treatment of childhood acute myelogenous leukemia. Pediatr Clin North Am. 1997;44(4):847-62.
21. SEER Stat Fact Sheets: Leukemia. National Cancer Institute. 2024.
22. American Cancer Society. Survival rates for childhood leukemia. Archived. 2014.
23. Stock W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc HematolEduc Program. 2010;2010:21-29.
24. Howard SC, Trifilio S, Gregory TK, Baxter N, McBride A. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Ann Hematol. 2016;95(4):563-73.
25. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875-91.
26. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083-95.
27. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427-31
28. Hahnemann S. Organon of Medicine: Fifth and Sixth Edition Combined. Boericke W, translator. New Delhi: B. Jain Publishers; 2002.
29. Kent JT. Repertory of the Homeopathic Materia Medica. 6th ed. New Delhi: B. Jain Publishers; 1998.
30. Phatak SR. A Concise Repertory of Homoeopathic Medicines. 2nd ed. New Delhi: B. Jain Publishers; 1996.
31. Murphy R. Homoeopathic Medical Repertory. 3rd ed. Virginia: Lotus Health Institute; 2010.
32. Roberts HA. The Principles and Art of Cure by Homoeopathy. New Delhi: B. Jain Publishers; 2002.
33. Anshutz EP. A Guide to the Twelve Tissue Remedies. New Delhi: B. Jain Publishers; 2002.
34. Boericke W. Pocket Manual of Homoeopathic Materia Medica & Repertory. New Delhi: B. Jain Publishers; 2002.
35. Dewey WA. Practical Homoeopathic Therapeutics. New Delhi: B. Jain Publishers; 2002.
36. Shaji Kumar RT. Holistic treatment of chronic myeloid leukaemia with adjuvant homoeopathic therapy: A case report. Ind J Res Homeopat. 2020;14(1):50.
Published
17/12/2025
Statistics
241 Views | 110 Downloads
Citatons
How to Cite
Kumar, D., R. Bhaduri, P. Parui, A. Dey, P. Hembrom, and D. Nandi. “Role of Homoeopathy in Leukemia: An Updated Holistic Review”. International Journal of Alternative and Complementary Medicine, Vol. 6, no. 2, Dec. 2025, pp. 21-25, doi:10.46797/ijacm.v6i2.775.
Issue
Section
Review Article
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.